Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steger-Hartmann

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Ernst Schering Foundation Symposium Proceedings|September 25, 2008
Oncogenes meet metabolism. From deregulated genes to a broader understanding of tumour physiology. PrefaceBjörn Riefke, Dominik Mumberg, Guido Kroemer, et al.
Environmental Toxicology and Chemistry|May 28, 2009
Effects of synthetic gestagens on fish reproductionJana Zeilinger, Thomas Steger-Hartmann, Edmund Maser, et al.
Investigative Radiology|July 21, 2010
A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosisThomas Steger-Hartmann, Rainer Hofmeister, Rainer Ernst, et al.
Regulatory Toxicology and Pharmacology : RTP|February 24, 2024
Replacing concurrent controls with virtual control groups in rat toxicity studiesAlexander Gurjanov, Carlos Vieira-Vieira, Julia Vienenkoetter, et al.
Drug Discovery Today|May 27, 2023
Perspectives of data science in preclinical safety assessmentThomas Steger-Hartmann, Annika Kreuchwig, Ken Wang, et al.
Journal of Chemical Information and Modeling|October 2, 2010
A maximum common subgraph kernel method for predicting the chromosome aberration testJohannes Mohr, Brijnesh Jain, Andreas Sutter, et al.
Investigative Radiology|March 3, 2009
Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agentsHubertus Pietsch, Philipp Lengsfeld, Thomas Steger-Hartmann, et al.
ALTEX|May 10, 2022
A microfluidic thyroid-liver platform to assess chemical safety in humansJulia Kühnlenz, Diana Karwelat, Thomas Steger-Hartmann, et al.
ALTEX|July 6, 2022
A rodent thyroid-liver chip to capture thyroid toxicity on organ function levelDiana Karwelat, Julia Kühnlenz, Thomas Steger-Hartmann, et al.
ALTEX|April 4, 2020
Introducing the concept of virtual control groups into preclinical toxicology testingThomas Steger-Hartmann, Annika Kreuchwig, Lea Vaas, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Ernst Schering Foundation Symposium Proceedings|September 25, 2008
Oncogenes meet metabolism. From deregulated genes to a broader understanding of tumour physiology. PrefaceBjörn Riefke, Dominik Mumberg, Guido Kroemer, et al.
Environmental Toxicology and Chemistry|May 28, 2009
Effects of synthetic gestagens on fish reproductionJana Zeilinger, Thomas Steger-Hartmann, Edmund Maser, et al.
Investigative Radiology|July 21, 2010
A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosisThomas Steger-Hartmann, Rainer Hofmeister, Rainer Ernst, et al.
Regulatory Toxicology and Pharmacology : RTP|February 24, 2024
Replacing concurrent controls with virtual control groups in rat toxicity studiesAlexander Gurjanov, Carlos Vieira-Vieira, Julia Vienenkoetter, et al.
Drug Discovery Today|May 27, 2023
Perspectives of data science in preclinical safety assessmentThomas Steger-Hartmann, Annika Kreuchwig, Ken Wang, et al.
Journal of Chemical Information and Modeling|October 2, 2010
A maximum common subgraph kernel method for predicting the chromosome aberration testJohannes Mohr, Brijnesh Jain, Andreas Sutter, et al.
Investigative Radiology|March 3, 2009
Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agentsHubertus Pietsch, Philipp Lengsfeld, Thomas Steger-Hartmann, et al.
ALTEX|May 10, 2022
A microfluidic thyroid-liver platform to assess chemical safety in humansJulia Kühnlenz, Diana Karwelat, Thomas Steger-Hartmann, et al.
ALTEX|July 6, 2022
A rodent thyroid-liver chip to capture thyroid toxicity on organ function levelDiana Karwelat, Julia Kühnlenz, Thomas Steger-Hartmann, et al.
ALTEX|April 4, 2020
Introducing the concept of virtual control groups into preclinical toxicology testingThomas Steger-Hartmann, Annika Kreuchwig, Lea Vaas, et al.
Pageof 7